Kedudukan dalam Saham
#20988
SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS,... SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS, specializes in creating pharmaceutical interventions for the acute exacerbation of inflammatory conditions. The company's primary investigational compound, AP1189, is currently being developed for the treatment of both rheumatoid arthritis and idiopathic membranous glomerulonephritis. Additionally, SynAct Pharma maintains a collaborative research initiative with the University of Örebro, focusing on the mitigation of inflammation in vascular diseases. Established in 2012, the firm's corporate headquarters are situated in Lund, Sweden.
Harga Saham
$2.22
Disegerakkan terakhir: 2026-08-21
Perubahan (1 tahun)
17.26%
Perdagangan SynAct Pharma AB (SYNACT)
Harga SYNACT dengan permodalan pasaran b
Modal pasaran bagi SynAct Pharma AB(SYNACT)
Modal Pasaran: $117.70M
Sehingga August 2026, SynAct Pharma AB mempunyai modal pasaran sebanyak $117.70M. Ini menjadikan SynAct Pharma AB syarikat ke-20988th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran SynAct Pharma AB dari 2016 hingga 2026
SYNACT berbanding dengan 5 teratas yang paling popular stocks
| Harga SYNACT |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.211T
|
+4,427,524.64%
|
|
|
|
|
$4.547T
|
+3,862,855.20%
|
|
|
|
|
$4.162T
|
+3,536,376.03%
|
|
|
|
|
$3.593T
|
+3,052,366.46%
|
|
|
|
|
$2.793T
|
+2,372,733.49%
|
